Obstructive Sleep Apnoea Syndrome in Children: What Can ENT Surgeons Offer?
Obstructive sleep apnoea syndrome (OSAS) is a result of periodic partial or total collapse of the pharynx during sleep. In children, this is usually due to adenotonsillar hypertrophy. Adenotonsillectomy is usually very effective although controversy exists on the feasibility and importance of routine preoperative polysomnogram (PSG). Apart from adenotonsillectomy, ENT surgeons can also treat nasal obstruction which may be important for certain patients. For those OSAS secondary to craniofacial malformations, it is usually necessary to perform tracheostomy until definitive corrective craniofacial surgery can be performed.
Keyword : Obstructive sleep apnoea syndrome; Sleep surgery
The disordered breathing of obstructive sleep apnoea syndrome (OSAS) patient is a result of periodic partial or total pharyngeal collapse during sleep. In children, it is most commonly caused by adenotonsillar hypertrophy. Other high risk groups include children with craniofacial malformations, neuromuscular disease and obesity.1 In managing this condition, ENT surgeons are involved in 3 main aspects ?firstly the management of adenotonsillar hypertrophy, secondly the management of nasal obstruction and finally, performing the tracheostomy for special cases.
Management of Adenotonsillar Hypertrophy
Adenotonsillar enlargement form the biggest group of OSAS in otherwise healthy children. The American Academy of Pediatrics recommends adenotonsillectomy as the first line treatment for most pediatric OSAS.2 In our locality, OSAS is also the major indication for tonsillectomy (with or without adenoidectomy) in children.3 Although the surgical risk is generally very small, there are concerns of potential immunological impairment after removal of the immunologically active tissue. While studies has shown that tonsillectomy may lead to certain changes in the cellular and humoral immunity markers, many of them are transient and there is no convincing evidence that they are clinically significant.4,5
The effectiveness of tonsillectomy and adenoidectomy in treating children OSAS is well reported. In a recent systematic review,6 adenoidectomy and tonsillectomy were found to be highly effective with an average reduction of AHI of 13.92 events and a success rate of 82.9% in normalising polysomnograms (PSG) parameters. This review included fourteen published studies which met the following inclusion criteria:-
The gold standard for diagnosing OSAS is nocturnal PSG but it is relatively seldomly employed due to its cost and limited accessibility. In a relevant survey of American otolaryngologists' practice patterns, 59% of adenotonsillectomies were performed for obstructed breathing and 39% specifically for OSAS. Interestingly, less than 10% of children underwent any objective testing prior to the surgery and less than 5% underwent laboratory-based PSG.7
The next question to be asked is how accurate is this clinical assessment? The answer is that the clinical evaluation is not very reliable, as concluded in a systematic review of the literature.8 In this meta-analysis, the recruited studies were heterogeneous in terms of diagnostic PSG criteria for OSAS but the overall conclusions of these articles were very consistent. As very few subjects with a negative clinical evaluation were included in any of these studies, the sensitivity and specificity, or negative predictive value could not be calculated. The weighted average of the positive predictive value for the studies with sufficient data provided was 55.8% (95% Confidence Interval: 42.1-69.6%). This may suggest that ENT surgeons (including the authors), who often made the diagnosis of children OSAS based on the clinical assessment alone, were frequently operating on children who actually do not need it.
However, things are not as simple as they appear and controversy exists. The controversy stems from the fact that, although PSG is regarded as the gold standard of diagnosing pediatric OSAS, the polysomnographic diagnostic criteria has not been well validated. This explains the heterogeneity of definitions in different studies. As the outcome data are severely lacking in pediatric OSAS, there is no study linking the diagnostic thresholds on PSG with undesirable outcomes in OSAS. A growing body of evidence suggests that snoring alone, even without OSAS or hypoxemia, may be associated with neurocognitive impairment.8,9 Kwok et al reported that children with primary snoring (with an Apnoea/Hypopnoea Index of 1 or less) have increased daytime systemic blood pressure and reduced arterial distensibility, which may jeopardise long-term cardiovascular health.10
Despite these uncertainties, to date, PSG is probably still the most objective and accepted diagnostic tool to guide treatment. Nevertheless, the decision to operate should also take into consideration the individual surgical risks as well as the severity and duration of the disease. In one study where a subgroup of children with mild OSAS (1
In recognition of the limitation of this approach, the ENT surgeon should select their surgical candidates cautiously. It is the authors' practice to operate without a PSG for those snoring children with gross adenotonsillar hypertrophy and florid obstructive symptoms e.g. impaired growth, frequently witnessed apnoea episodes or restless sleep on top of laboured breathing, etc. Those less symptomatic cases or with borderline enlarged tonsils would be observed or referred for PSG to aid the management decision. There are no absolute age limits for adenotonsillectomy providing that the indication is strong. For adenoid and tonsillar size estimation, there is no universally-accepted grading system that reliably predicts obstruction. For the adenoid, if it is big enough to cause nasal obstruction and otitis media with effusion with failed medical treatment, it is already an indication for surgery irrespective of the PSG findings. For tonsils, the grading systems adopted in various studies commonly used the tonsillar pillars and uvula as landmarks of cut off.11-15 Generally speaking, for descriptive purpose, tonsils with a medial extension close to or beyond the lateral edge of uvula are considered enlarged while those lie within the tonsillar fossae are considered small. However, where tonsils are not causing obstructive problems, they do not require excision even if they are apparently enlarged.
Management of Nasal Obstruction
Although the nasal lesions are not situated at the site of OSAS obstruction, they can be a source of upstream obstruction. This in turn would lead to increased negative inspiratory pressure downstream and thus causing and/or contributing to the pharyngeal collapse. Turbinate hypertrophy and deviated nasal septums are two of the commonest obstructive nasal diseases. Turbinate hypertrophy is a common finding in patients with allergic rhinitis. For deviated nasal septum, it is either developmental or secondary to previous trauma.
Intranasal steroids have been shown to improve nasal obstruction in atopic individuals and to reduce adenoidal size and obstructive symptoms.1 One randomised controlled trial showed improvement in the severity of OSAS in children treated with intranasal steroids.16 For those who have failed medical treatment, turbinate hypertrophy can be effectively treated by turbinate reduction surgery which are usually performed under general anesthesia for children. More recently, less invasive procedures - submucosal radiofrequency tissue reduction surgery - have been made available. This is an office procedure under local anesthesia and may be considered for well-selected and more mature patients.
For nasal septal deviation, because of concerns and some evidence of possible nasal growth interference, nasal septal surgery in children is usually postponed to the time when the nasal growth is deemed complete; this is usually 16 years of age for boys and 14 years of age for girls.17 In certain cases with very bad septal deviations or congenital problems, earlier septal surgery may be considered or even deemed necessary. It has been shown that nasal surgery, which improves the nasal patency, can reduce CPAP pressure requirement,17 improve RDI or even abolish OSAS in some patients.18
Tracheostomy is almost always effective in treating OSAS. It bypasses any pharyngeal obstruction during awake and sleep. While it is a relatively simple and safe procedure for adults, it is not the case for paediatric patients. It carries a complication rate of 31-44%19-21 with a tracheostomy-related deaths of about 3%.19,20 Early complications include bleeding, blocked tube, tube dislodgement, wound infection, peumothorax, etc. Late complications remain tube dislodgement, suprastomal granulation requiring surgery, tracheocutaneous fistula and tracheomalacia. Nevertheless, it is often needed for those OSAS children secondary to craniofacial abnormalities as the planned corrective surgical procedures carry a high mortality until the child is several years of age.22 Decannulation is only possible when mandibular expansion or midface advancement (which are usually performed by maxillofacial surgeons) has improved the naso- and oropharyngeal airways.
Other considerations in children with OSAS include obesity. While the association of OSAS and obesity is weak in young or pre-pubertal children, this association has been shown to be significantly stronger in adolescents in a number of studies.23 In fact, a local study actually found a strong association between obesity and OSAS in a young age group of 7-11 years (32.6% vs 4.5% in the normal-weight peers),24 possibly reflecting some racial difference in the body fat distribution and craniofacial features. Therefore overweight children may need a lower threshold for proper investigation and treatment, and a more vigilant surveillance for residual disease after adenotonsillectomy.
Lastly, more studies are needed to better define the PSG and clinical criteria for diagnosis and treatment guidance.
1. Nixon GM, Brouillette RT. Sleep. 8: paediatric obstructive sleep apnoea. Thorax 2005;60:511-6.
2. Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. American Academy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:704-12.
3. Wong BYH, Ng YW, Hui Y. A 10 year review of tonsillectomy in a tertiary center. HK J Paediatr (new series) 2007;12:297-9.
4. Zielnik-Jurkiewicz B. Jurkiewicz D. Implication of immunological abnormalities after adenotonsillotomy. Int J Pediatr Otorhinolaryngol 2002;64:127-32.
5. Böck A. Popp W. Herkner KR. Tonsillectomy and the immune system: a long-term follow up comparison between tonsillectomized and non-tonsillectomized children. Eur Arch Otorhinolaryngol 1994;251:423-7.
6. Brietzke SE, Gallagher D. The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol Head Neck Surg 2006;134:976-84.
7. Weatherly RA, Mai EF, Ruzicka DL, et al. Identification and evaluation of obstructive sleep apnea prior to adenotonsillectomy in children: a survey of practice patterns. Sleep Med 2003;4:297-307.
8. Brietzke SE, Katz ES, Roberson DW. Can history and physical examination reliably diagnose pediatric obstructive sleep apnea/ hypopnea syndrome? A systematic review of the literature. Otolarygnol Head Neck Surg 2004;131:827-32.
9. O'Brien LM, Mervis CB, Holbrook CR, et al. Neurobehavioral implications of habitual snoring in children. Pediatrics 2004;114:44-9.
10. Kwok KL, Ng DK, Cheung YF. BP and arterial distensibility in children with primary snoring. Chest 2003;123:1561-6.
11. Nieminen P, Tolonen U, Löppönen H. Snoring and obstructive sleep apnea in children- a 6-month follow-up study. Arch Otolaryngol Head Neck Surg 2000;126:481-6.
12. Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg 1995;121:525-30.
13. Wang RC, Elkins TP, Keech D, Wauquier A, Hubbard D. Accuracy of clinical evaluation in pediatric obstructive sleep apnea. Otolaryngol Head Neck Surg 1998;118:69-73.
14. Jain A, Sahni JK. Polysomnographic studies in children undergoing adenoidectomy and/or tonsillectomy. J Laryngol Otol 2002;116;711-5.
15. Nieminen P, Tolonen U, Löppönen H, Löppönen T, Luotonen J, Jokinen K. Snoring children: factors predicting sleep apnea. Acta Otolaryngol (Stockh) 1997;S529:190-4.
16. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838-44.
17. Béjar I, Farkas LG, Massner AH, Crysdale WS. Nasal growth after external septoplasty in children. Arch Otolaryngol Head Neck Surg 1996;122:816-21.
18. Darrow DH. Surgery for Pediatric sleep apnea. Otolaryngol Clin North Am 2007;40:855-75.
19. Gaudet PT, Peerless A, Sasaki CT, Kirchner JA. Pediatric tracheostomy and associated complications. Laryngoscope 1978;88:1633-41.
20. Carron JD, Derkay CS, Strope GL, Nosonchuk JE, Darrow DH. Pediatric tracheotomies: changing indications and outcomes. Laryngoscope 2000;110:1099-104.
21. Ang AHC, Chua DYK, PangKP, Tan HKK. Pediatric tracheostomies in an Asian Population: the Singapore experience. Otolaryngol Head Neck Surg 2005;133:246-50.
22. Sculerati N, Gottlieb MD, Zimbler MS, Chibbaro PD, McCarthy JG. Airway management in children with major craniofacial anomalies. Laryngoscope 1998;108:1806-12.
23. Ievers-Landis CE, Redline S. Pediatric sleep apnea- implications of the epidemic of childhood overweight. Am J Respir Crit Care Med 2007;175:436-41.
24. Wing YK, Hui SH, Pak WM, et al. A controlled study of sleep related disordered breathing in obese children. Arch Dis Child 2003;88:1043-7.
This web site is sponsored by Johnson & Johnson (HK) Ltd.